These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 620840)

  • 1. The effect of intrauterine devices containing zinc and copper on their levels in serum.
    Anteby SO; Bassat HA; Yarkoni S; Aboulafia Y; Sadovsky E
    Fertil Steril; 1978 Jan; 29(1):30-4. PubMed ID: 620840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum copper in long-term users of copper intrauterine devices.
    Prema K; Lakshmi BA; Babu S
    Fertil Steril; 1980 Jul; 34(1):32-5. PubMed ID: 7398904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and endometrial copper, zinc, iron and cobalt with inert and copper-containing IUCDs.
    Fahmy K; Ghoneim M; Eisa I; el-Gazar A; Afifi A
    Contraception; 1993 May; 47(5):483-90. PubMed ID: 8513675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cortisol level in lactating women using Progestasert system.
    Askalani H; Badraoui MH; Mahrous T; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
    Popul Sci; 1981; (2):109-14. PubMed ID: 12339476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum prolactin levels in lactating women using progestasert system.
    Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
    Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum prolactin concentrations related to copper or inert intrauterine devices (IUDs) in women.
    Ransom WT; Chapman RS; Hull MG
    Contraception; 1979 Nov; 20(5):441-6. PubMed ID: 527340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in intrauterine devices.
    Farr G
    Netw Res Triangle Park N C; 1991 Sep; 12(2):9. PubMed ID: 12284281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of serum ferritin in anemia development after insertion of T Cu 220 intrauterine device.
    Piedras J; Córdova MS; Pérez-Toral MC; Lince E; Garza-Flores J
    Contraception; 1983 Mar; 27(3):289-97. PubMed ID: 6851561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the Gyne-T 380S IUD on menstrual blood loss and iron status.
    Milsom I; Andersson K; Jonasson K; Lindstedt G; Rybo G
    Contraception; 1995 Sep; 52(3):175-9. PubMed ID: 7587189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Copper-7 intrauterine device (Gravigard). Report of experience].
    Jürgensen O; Stenzel I; Wirth A; Sina D; Taubert HD
    Fortschr Med; 1976 Mar; 94(9):515-21. PubMed ID: 964914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three different models of the copper T intrauterine contraceptive device.
    Roy S; Casagrande J; Cooper DL; Mishell DR
    Am J Obstet Gynecol; 1979 Jul; 134(5):568-74. PubMed ID: 453297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in copper and zinc serum levels in women wearing a copper TCu-380A intrauterine device.
    Imani S; Moghaddam-Banaem L; Roudbar-Mohammadi S; Asghari-Jafarabadi M
    Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):45-50. PubMed ID: 24304153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in cervical mucus copper and zinc in women using I.U.D.s.
    Tagi AH; Awad AH; El Hemaly AK; Ibrahim H; El Masry GI; Morad M
    Popul Sci; 1985; 6():35-40. PubMed ID: 12349092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of serum iron indices and haemoglobin concentration following copper-IUD insertion.
    Goh TH; Hariharan M; Tan CH
    Contraception; 1980 Oct; 22(4):389-95. PubMed ID: 7449387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intrauterine contraception in women over 35-years old: comparison between copper and progesterone IUDs].
    Calzolari E; Galoppi P; Masala L; Parisi C; Iannucci D; Salmaggi P; Custo GM; Zichella L
    Patol Clin Ostet Ginecol; 1985; 13(1):49-56. PubMed ID: 12342024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.